Clinical Trials Alzheimer’s Disease: AR1001 – Biological drug to treat early symptoms of Alzheimer’s Disease ADUHELM™ also known as BIIB037 LY3002813 – Biological drug to treat early symptoms of Alzheimer’s Disease PM8200 – A single or multiple visit protocol for collection of DNA/RNA/Serum/Plasma/CSF in Normal Donors I5T-MC-AACI – Assessment of Safety, Tolerability, and Efficacy of Donanemab View All Multiple Sclerosis: EFC16033 & EFC16033 Actigraphy (Gemini) EFC16035 & EFC16035 Actigraphy (PERSEUS) P2-IMU-838-PMS – Patients with Progressive Multiple Sclerosis GN43271 – A biological drug to treat relapsing Multiple Sclerosis EFC16045 – Nonrelapsing secondary progressive multiple sclerosis (HERCULES) View All Pediatric Migraine: 3110-306-002 – Migraine with or without aura in children and adolescents (ages 6-17) 3110-305-002 – Migraine with or without Aura in Children or Adolescents (age 6-17) BHV3000-312 – Migraine (With or Without Aura) in Children and Adolescents. View All ALS: PM4800 – Amyotrophic Lateral Sclerosis and Related Disorder View All
